The invention provides methods for treating an individual having a retinoid responsive disorder. In one embodiment, a method involves administering to the individual an effective amount of a selective CYP26B inhibitor, the selective CYP26B inhibitor having at least 10-fold selectivity for CYP26B relative to CYP26A. In another embodiment, a method involves administering to the individual an effective amount of a selective CYP26A inhibitor, the selective CYP26A inhibitor having a chemical formula set forth in the specification. The invention further provides screening methods for identifying a selective CYP26A inhibitor or selective CYP26B inhibitor.

 
Web www.patentalert.com

< Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors

> Sterile pharmaceutical composition and process for a solution of propofol emulsion having microbial growth retardation

~ 00485